Cargando…
Glial Fibrillary Acidic Protein Is Not an Early Marker of Injury in Perinatal Asphyxia and Hypoxic–Ischemic Encephalopathy
Brain-specific glial fibrillary acidic protein (GFAP) has been suggested as a potential biomarker for hypoxic ischemic encephalopathy (HIE) in newborns (1, 2). Previous studies have shown increased levels in post-natal blood samples. However, its ability to guide therapeutic intervention in HIE is u...
Autores principales: | Looney, Ann-Marie, Ahearne, Caroline, Boylan, Geraldine B., Murray, Deirdre M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685091/ https://www.ncbi.nlm.nih.gov/pubmed/26733938 http://dx.doi.org/10.3389/fneur.2015.00264 |
Ejemplares similares
-
Predictive modelling of hypoxic ischaemic encephalopathy risk following perinatal asphyxia
por: Mooney, Catherine, et al.
Publicado: (2021) -
Seizure burden and neurodevelopmental outcome in neonates with hypoxic–ischemic encephalopathy
por: Kharoshankaya, Liudmila, et al.
Publicado: (2016) -
Metabolomic Profiling in Perinatal Asphyxia: A Promising New Field
por: Denihan, Niamh M., et al.
Publicado: (2015) -
The Usefulness of Serum Brain Damage Biomarkers in Detection and Evaluation of Hypoxic Ischemic Encephalopathy in Calves with Perinatal Asphyxia
por: Ok, Mahmut, et al.
Publicado: (2022) -
Perinatal Hypoxic-Ischemic Encephalopathy
por: Lai, Ming-Chi, et al.
Publicado: (2011)